" They are understanding, that by controlling cell
Post# of 146038
& that is why Cytodyn shareholders have a backwards assumption on big pharma.
Pharma can now have through Leronlimab, a tool to benefit, from the changes.
Once shareholders & market realize / sees this, it'll be a total shock --- many times a FOMO effect
& "pharma" will have already been executing, behind the scenes, their flip flop strategy.
Pharma will be embracing the hell out of this company/drug via great deals.
Just a matter of time.
100% opposite of shareholders thinking over the yrs.
: )
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)